Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care

ClinicalTrials.gov ID: NCT03711162

Public ClinicalTrials.gov record NCT03711162. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Two Doses of GLPG1690 in Addition to Local Standard of Care for Minimum 52 Weeks in Subjects With Idiopathic Pulmonary Fibrosis

Study identification

NCT ID
NCT03711162
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Lakefront Biotherapeutics NV
Industry
Enrollment
525 participants

Conditions and interventions

Interventions

  • GLPG1690 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 27, 2018
Primary completion
Mar 29, 2021
Completion
Mar 29, 2021
Last update posted
Jul 28, 2022

2018 – 2021

United States locations

U.S. sites
47
U.S. states
29
U.S. cities
45
Facility City State ZIP Site status
Pulmonary Associates Phoenix Arizona 85006
Mayo Clinic Arizona - PPDS Scottsdale Arizona 85259
Atria Clinical Research - BTC - PPDS Little Rock Arkansas 72209
David Geffen School of Medicine at UCLA Los Angeles California 90095
Respire Research Palm Springs California 92262
University of California San Diego San Diego California 92037
Stanford University Medical Center Stanford California 94305
University of Colorado Aurora Colorado 80045
National Jewish Health Denver Colorado 80206
Western Connecticut Medical Group Danbury Connecticut 06810
Yale University School of Medicine New Haven Connecticut 06510
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007
PAB Clinical Research - ClinEdge - PPDS Brandon Florida 33511
St. Francis Medical Institute - BTC - PPDS Clearwater Florida 33765
North Florida/South Georgia Veterans Health System-NAVREF-PPDS Gainesville Florida 32608
University of Florida Gainesville Florida 32610
Advanced Pulmonary Research Institute Loxahatchee Groves Florida 33470
Northwestern Memorial Hospital Chicago Illinois 60611
Pulmonary and Infections Disease Associates Council Bluffs Iowa 51503
University of Louisville Louisville Kentucky 40202
Tulane Medical Center New Orleans Louisiana 70112
University of Maryland Medical Center Baltimore Maryland 21201
Massachusetts General Hospital, Division of Pulmonary and Critical Care Medicine Boston Massachusetts 02114
Caritas St. Elizabeth's Medical Center Boston Massachusetts 02135
Henry Ford Health System Dearborn Michigan 48124
Minnesota Lung Center Minneapolis Minnesota 55407
Mayo Clinic - PPDS Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Creighton University Omaha Nebraska 68131
University of Rochester Medical Center - PPDS Rochester New York 14642
PulmonIx LLC Greensboro North Carolina 27403
UC Health Department of Internal Medicine, Pulmonary, Critical Care & Sleep Medicine Cincinnati Ohio 45267
Cleveland Clinic Cleveland Ohio 44195-0001
The Oregon Clinic Portland Oregon 97220
Penn State Milton S Hershey Medical Center Hershey Pennsylvania 17033
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
Rhode Island Hospital Providence Rhode Island 02903
Vanderbilt University Medical Center Nashville Tennessee 37232
University of Texas Southwestern Medical Center Dallas Texas 75390
Houston Methodist Hospital Houston Texas 77030
Metroplex Pulmonary and Sleep Medicine Center McKinney Texas 75069
University of Texas Health Science Center San Antonio San Antonio Texas 78229
University of Utah Medical Care Salt Lake City Utah 84108
University of Virginia Charlottesville Virginia 22908
Western Washington Medical Group Everett Washington 98208
University of Washington Medical Center Seattle Washington 98195
University of Wisconsin Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 85 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03711162, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2022 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03711162 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →